Page last updated: 2024-10-18

dalteparin and Hyperpotassemia

dalteparin has been researched along with Hyperpotassemia in 9 studies

Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)

Research Excerpts

ExcerptRelevanceReference
"Hyperkalemia is an infrequent but potentially serious complication of low molecular weight heparin (LMWH) use."2.79Effects of 8,000 IU aXa long-term prophylaxis with certoparin on the incidence of hyperkalemia in patients with coronary heart disease--a post-hoc analysis of the PARAT trial. ( Bramlage, P; Melzer, N; Michaelis, HC, 2014)
"The cause of hyperkalemia is frequently iatrogenic."1.72[Hyperkalemia due to low-molecular-weight heparin]. ( Appelman-Dijkstra, NM; den Exter, PL; Koopman, JJEB; van der Heiden, W, 2022)

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (11.11)18.2507
2000's3 (33.33)29.6817
2010's4 (44.44)24.3611
2020's1 (11.11)2.80

Authors

AuthorsStudies
van der Heiden, W1
Koopman, JJEB1
Appelman-Dijkstra, NM1
den Exter, PL1
Gheno, G1
Cinetto, L1
Savarino, C1
Vellar, S1
Carraro, M1
Randon, M1
Torres, OH1
Hernandez, N1
Francia, E1
Barcelo, M1
Mateo, J1
Ruiz, D1
Rocha, E1
Gómez-Outes, A1
Martínez González, J1
Kakkar, VV1
Danguy, C1
Biston, P1
Carlier, E1
Defrance, P1
Piagnerelli, M1
Koren-Michowitz, M1
Avni, B1
Michowitz, Y1
Moravski, G1
Efrati, S1
Golik, A1
Wiggam, MI1
Beringer, TR1
Melzer, N1
Bramlage, P1
Michaelis, HC1
Shimokaze, T1
Akaba, K1
Saito, E1

Trials

4 trials available for dalteparin and Hyperpotassemia

ArticleYear
Variations of serum potassium level and risk of hyperkalemia in inpatients receiving low-molecular-weight heparin.
    European journal of clinical pharmacology, 2003, Volume: 59, Issue:5-6

    Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Enoxaparin; Female; Humans; Hyperkalemia; Logistic M

2003
Effect of prophylactic treatment with low-molecular-weight heparin bemiparin sodium on serum potassium levels: a prospective observational study.
    Drugs & aging, 2010, Volume: 27, Issue:5

    Topics: Aged; Female; Heparin, Low-Molecular-Weight; Humans; Hyperkalemia; Male; Potassium; Prospective Stud

2010
Early onset of hyperkalemia in patients treated with low molecular weight heparin: a prospective study.
    Pharmacoepidemiology and drug safety, 2004, Volume: 13, Issue:5

    Topics: Aldosterone; Anticoagulants; Creatinine; Enoxaparin; Female; Humans; Hydrogen-Ion Concentration; Hyp

2004
Effects of 8,000 IU aXa long-term prophylaxis with certoparin on the incidence of hyperkalemia in patients with coronary heart disease--a post-hoc analysis of the PARAT trial.
    BMC research notes, 2014, Dec-06, Volume: 7

    Topics: Aged; Anticoagulants; Coronary Artery Disease; Double-Blind Method; Female; Heparin, Low-Molecular-W

2014

Other Studies

5 other studies available for dalteparin and Hyperpotassemia

ArticleYear
[Hyperkalemia due to low-molecular-weight heparin].
    Nederlands tijdschrift voor geneeskunde, 2022, 06-20, Volume: 166

    Topics: Anticoagulants; Heparin; Heparin, Low-Molecular-Weight; Humans; Hyperkalemia; Hypoaldosteronism; Mal

2022
Effect of unfractionated heparin and long-term treatment with low-molecular-weight heparin, bemiparin, on potassium levels.
    Thrombosis and haemostasis, 2005, Volume: 94, Issue:5

    Topics: Anticoagulants; Heparin, Low-Molecular-Weight; Humans; Hyperkalemia; Potassium; Thrombosis

2005
Severe hyperkalemia in critically ill patients treated with prophylactic doses of enoxaparin.
    Intensive care medicine, 2012, Volume: 38, Issue:11

    Topics: Aged; Enoxaparin; Female; Fibrinolytic Agents; Humans; Hyperkalemia; Intensive Care Units; Male; Mid

2012
Effect of low-molecular-weight heparin on serum concentrations of potassium.
    Lancet (London, England), 1997, Jul-26, Volume: 350, Issue:9073

    Topics: Aged; Aged, 80 and over; Anticoagulants; Enoxaparin; Female; Humans; Hyperkalemia

1997
Heparin-induced hyperkalemia in an extremely-low-birth-weight infant: a case report.
    Journal of clinical research in pediatric endocrinology, 2014, Volume: 6, Issue:2

    Topics: Anticoagulants; Dalteparin; Female; Heparin; Humans; Hyperkalemia; Infant, Newborn; Infant, Very Low

2014